LORI OROSS: Open Payments
NPI 1861903502 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$63 in 3 payments from 3 companies in 2025. Trend: 2023 $148 · 2024 $0 · 2025 $63
Food & beverage: $63
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
Products named: REZDIFFRA, IQIRVO.
Industry payments across MD — which companies pay providers there.
